Skip to main content
. Author manuscript; available in PMC: 2016 Jun 7.
Published in final edited form as: Ann Surg. 2015 Jan;261(1):125–128. doi: 10.1097/SLA.0000000000000588

Table. Preoperative Characteristics of GLP-1 Users and Nonusers According to Insulin.

No Insulin (N = 57) Insulin (N = 91)


GLP-1 (N = 14) No GLP-1 (N = 43) P GLP-1 (N = 23) No GLP-1 (N = 68) P
Age mean (SD), yrs 47.9 (7.8) 48.8 (10.7) 0.770 53.2 (6.7) 53.7 (9.3) 0.790
Gender
 Male 36% (n = 5) 19% (n = 8) 0.271 35% (n = 8) 38% (n = 26) 0.767
 Female 64% (n = 9) 81% (n = 35) 65% (n = 15) 62% (n = 42)
Race
 White 100% (n = 14) 100% (n = 43) NA 100% (n = 23) 99% (n = 67) 0.999
 Other 0% (n = 0) 0% (n = 0) 0% (n = 0) 1% (n = 1)
Diabetes medication
 Metformin 79% (n = 11) 95% (n = 41) 0.089 74% (n = 17) 62% (n = 42) 0.292
 Other ISA 50% (n = 7) 30% (n = 13) 0.209 30% (n = 7) 46% (n = 31) 0.203
 Sulfonylureas 71% (n = 10) 44% (n = 19) 0.123 57% (n = 13) 32% (N = 22) 0.039
HbA1c, mean (SD), % 7.0 (1.5) 6.8 (1.1) 0.571 8.6 (1.8) 8.6 (1.6) 0.880
Glucose, mean (SD), mg/dL 148 (72) 118 (37) 0.158 164 (98) 166 (94) 0.934
Serum insulin, mean (SD), μU/mL 24.7 (17.7) 26.9 (36.7) 0.774 20.5 (13.2) 19.9 (14.4) 0.871

P values were generated from 2-sample t test (continuous data) or χ2 test (categorical data).

ISA indicates other insulin-sensitizing agent.